Abbott Offers Fixes To Clear $25B St. Jude Deal In EU
Abbott Laboratories has offered remedies to alleviate concerns that its $25 billion cash-and-stock acquisition of medical device maker St. Jude Medical will harm competition in the European Union, according to a...To view the full article, register now.
Already a subscriber? Click here to view full article